Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sebastjan Merlo"'
Autor:
Gregor Vivod MD, Nina Kovacevic MD, PhD, Maja Čemažar PhD, Gregor Serša PhD, Tanja Jesenko PhD, Maša Bošnjak PhD, Simona Kranjc Brezar PhD, Sebastjan Merlo MD, PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 21 (2022)
Objective : Pelvic exenteration in women with recurrent vulvar carcinoma is associated with high morbidity and mortality and substantial treatment costs. Because pelvic exenteration severely affects the quality of life and can lead to significant com
Externí odkaz:
https://doaj.org/article/51c26c9148774dfe95edd1a41bedfccf
Autor:
Sebastjan Merlo MD, PhD, Gregor Vivod MD, Sonja Bebar MD, Maša Bošnjak PhD, Maja Čemažar PhD, Gregor Serša PhD, Simona Kranjc Brezar PhD, Nina Kovačević MD, PhD
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Endometrial carcinoma is the most common gynecological malignancy and the fifth most common malignancy in women. The worldwide incidence is 15.9 new cases per 100,000 women per year, and the incidence in Europe is 22.7 new cases. Minority of cases ar
Externí odkaz:
https://doaj.org/article/efc58fded575464b92d9fe35603ae460
Autor:
Gregor Vivod, Sebastjan Merlo, Maja Čemažar, Simona Kranjc Brezar, Nina Kovačević, Masa Bosnjak, Gregor Sersa, Sonja Bebar
Publikováno v:
Technology in Cancer Research & Treatment, Vol 20 (2021)
Technology in cancer research and treatment, vol. 20, 2021.
Technology in Cancer Research & Treatment
Technology in cancer research and treatment, vol. 20, 2021.
Technology in Cancer Research & Treatment
Endometrial carcinoma is the most common gynecological malignancy and the fifth most common malignancy in women. The worldwide incidence is 15.9 new cases per 100,000 women per year, and the incidence in Europe is 22.7 new cases. Minority of cases ar